Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 90,556,840
- Total 13F value
- $1,986,081,198
- Share change
- +19,334,680
- Put/Call ratio
- 63%
- SEC-reported price per share
- $22.00
- Number of holders
- 111
- Value change
- +$169,321,459
- Number of buys
- 91
- Number of sells
- 27
- Shares outstanding
- 305,667,944
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
111
Top holders
10
ABCL full security history
Ownership snapshot
Full 13F holder table
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 6.2%
Showing 1-6 of 15 holder rows.
Quick read
VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 6.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership
Top 5
VIKING GLOBAL INVESTORS LP
6.2%
BAKER BROS. ADVISORS LP
3.4%
ORBIMED ADVISORS LLC
2.7%
SB Management Ltd
2.6%
Capital World Investors
1.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
6.2%
|
$648,084,000
19,083,744 shares
|
— | 31 Mar 2021 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
3.4%
|
$354,888,000
10,450,180 shares
|
— | 31 Mar 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
2.7%
|
$278,498,000
8,200,768 shares
|
— | 31 Mar 2021 |
| SB Management Ltd |
13F
Company
|
2.6%
|
$265,472,000
7,817,190 shares
|
— | 31 Mar 2021 |
| Capital World Investors |
13F
Company
|
1.4%
|
$141,303,000
4,160,870 shares
|
— | 31 Mar 2021 |
| HARVARD MANAGEMENT CO INC |
13F
Company
|
1.3%
|
$139,409,000
4,105,095 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
111
Shares
90,556,840
Rows available
111
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
82
Q2 2021 holders
111
Holder diff
29
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|